Year: 2020
Type: letter
Abstract: This letter to the editor questions whether liquid next-generation sequencing is a reasonable substitute for tissue next-generation sequencing for all forms of appendiceal cancer.
Source: The Oncologist
DOI: 10.1002/onco.13559
Author: John Paul Shen
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: National Cancer Institute
OpenAlex ID: W3092504914
